Jacob George

Serum PRO‐C3 is useful for risk prediction and fibrosis assessment in MAFLD with chronic kidney disease in an Asian cohort

Dan-Qin Sun, D. Leeming, T. Yip, 2024, Liver international (Print).

NR1H4 rs35724 G>C Variant Modulates Liver Damage in Nonalcoholic Fatty Liver Disease

L. N. Valenti, J. Pihlajamäki, H. Yki-Järvinen, 2020, SSRN Electronic Journal.